Author:
Publisher: Elsevier
ISBN: 0128181591
Category : Science
Languages : en
Pages : 242
Book Description
Smokeless Tobacco Products: Characteristics, Usage, Health Effects, and Regulatory Implications, a title in the Emerging Issues in Analytical Chemistry series, presents an overview of research on the second most dangerous tobacco product. This book presents findings on public health risks emanating from the complex interaction between smokeless tobacco products and their users. It covers the key components of assessment and provides insight into scientific and public health considerations. The book does not take a simplistic condemnatory position, but rather conceptualizes tobacco use in terms of graduated public health danger and harm reduction. The book begins by introducing smokeless tobacco, its history of use, marketing, and implications for public health. It then continues with coverage of epidemiology, pathology and clinical implications, addiction, and treatment, and includes laboratory studies of human use. The following section explains the chemistry, biochemical mechanisms of carcinogenesis, and role of plant cultivation and manufacturing in toxicity. Finally, the book concludes by addressing regulatory considerations, the scientific basis of regulations, and the role of these products in harm reduction for smokers. This is the first resource of its kind to cover these topics together and in language appropriate to both specialists in the research community and informed persons responsible for legislative, funding, and public health matters in the community at large. - Brings attention to smokeless tobacco product use and its association with addiction and disease - Considers smokeless tobacco use historically and currently, as well as its place in a future harm-reduction conceptualization of tobacco - Written by a distinguished, internationally recognized group of tobacco researchers from academia, independent research organizations, and the federal government with expertise in the many and various disciplines covered
Smokeless Tobacco Products
For Smokers Only
Author: MD Brad Rodu
Publisher:
ISBN: 9781939104304
Category : Health & Fitness
Languages : en
Pages : 190
Book Description
If you smoke and are unable or unwilling to quit, this approach can save your life. The book, For Smokers Only: How Smokeless Tobacco Can Save Your Life, provides concrete facts and valuable advice on a revolutionary quit-smoking strategy that is based on scientific research and common sense. Itis written by Dr. Brad Rodu, a leading authority on tobacco harm reduction, and a professor and senior scientist at the University of Alabama/Birmingham Comprehensive Cancer Center. Dr. Roduis stop-smoking strategy is based on three simple facts: 1. Smokers are addicted to nicotine, but nicotine does not cause cancer, heart attacks or emphysema. Those illnesses are caused by the other 3000 products of tobacco combustion. 2. Smokeless tobacco satisfies nicotine craving, but smokeless is 98% safer than smoking. 3. Todayis smokeless, spitless tobacco products can be used invisibly anytime, anywhere, much like a breath mint. "Please surf this site for lots of useful, factual information that can save your life, and the lives of your friends and loved ones." -- Dr. Brad Rodu"
Publisher:
ISBN: 9781939104304
Category : Health & Fitness
Languages : en
Pages : 190
Book Description
If you smoke and are unable or unwilling to quit, this approach can save your life. The book, For Smokers Only: How Smokeless Tobacco Can Save Your Life, provides concrete facts and valuable advice on a revolutionary quit-smoking strategy that is based on scientific research and common sense. Itis written by Dr. Brad Rodu, a leading authority on tobacco harm reduction, and a professor and senior scientist at the University of Alabama/Birmingham Comprehensive Cancer Center. Dr. Roduis stop-smoking strategy is based on three simple facts: 1. Smokers are addicted to nicotine, but nicotine does not cause cancer, heart attacks or emphysema. Those illnesses are caused by the other 3000 products of tobacco combustion. 2. Smokeless tobacco satisfies nicotine craving, but smokeless is 98% safer than smoking. 3. Todayis smokeless, spitless tobacco products can be used invisibly anytime, anywhere, much like a breath mint. "Please surf this site for lots of useful, factual information that can save your life, and the lives of your friends and loved ones." -- Dr. Brad Rodu"
Spit Tobacco
Author:
Publisher: DIANE Publishing
ISBN: 9781422314517
Category : Athletes
Languages : en
Pages : 24
Book Description
Publisher: DIANE Publishing
ISBN: 9781422314517
Category : Athletes
Languages : en
Pages : 24
Book Description
From Clinical Trials to Community
Author:
Publisher:
ISBN:
Category : Biology
Languages : en
Pages : 84
Book Description
Publisher:
ISBN:
Category : Biology
Languages : en
Pages : 84
Book Description
Cigars
Author: National Cancer Institute (U.S.)
Publisher:
ISBN:
Category : Cigar smoke
Languages : en
Pages : 258
Book Description
Identifies upward trend in cigar use as potential serious public health problem.
Publisher:
ISBN:
Category : Cigar smoke
Languages : en
Pages : 258
Book Description
Identifies upward trend in cigar use as potential serious public health problem.
The Health Benefits of Smoking Cessation
Author: United States. Public Health Service. Office of the Surgeon General
Publisher:
ISBN:
Category : Health promotion
Languages : en
Pages : 670
Book Description
Publisher:
ISBN:
Category : Health promotion
Languages : en
Pages : 670
Book Description
Smokeless Tobacco: Not a Safe Alternative
Author: Katie John Sharp
Publisher: Simon and Schuster
ISBN: 1422297764
Category : Juvenile Nonfiction
Languages : en
Pages : 113
Book Description
For years now we've all heard the dangers of smoking cigarettes. To avoid those health risks, many people have turned to "chew," "plug," "chaw"-smokeless tobacco. No smoke, no danger. Right?
Publisher: Simon and Schuster
ISBN: 1422297764
Category : Juvenile Nonfiction
Languages : en
Pages : 113
Book Description
For years now we've all heard the dangers of smoking cigarettes. To avoid those health risks, many people have turned to "chew," "plug," "chaw"-smokeless tobacco. No smoke, no danger. Right?
How Tobacco Smoke Causes Disease
Author: United States. Public Health Service. Office of the Surgeon General
Publisher:
ISBN:
Category : Government publications
Languages : en
Pages : 728
Book Description
This report considers the biological and behavioral mechanisms that may underlie the pathogenicity of tobacco smoke. Many Surgeon General's reports have considered research findings on mechanisms in assessing the biological plausibility of associations observed in epidemiologic studies. Mechanisms of disease are important because they may provide plausibility, which is one of the guideline criteria for assessing evidence on causation. This report specifically reviews the evidence on the potential mechanisms by which smoking causes diseases and considers whether a mechanism is likely to be operative in the production of human disease by tobacco smoke. This evidence is relevant to understanding how smoking causes disease, to identifying those who may be particularly susceptible, and to assessing the potential risks of tobacco products.
Publisher:
ISBN:
Category : Government publications
Languages : en
Pages : 728
Book Description
This report considers the biological and behavioral mechanisms that may underlie the pathogenicity of tobacco smoke. Many Surgeon General's reports have considered research findings on mechanisms in assessing the biological plausibility of associations observed in epidemiologic studies. Mechanisms of disease are important because they may provide plausibility, which is one of the guideline criteria for assessing evidence on causation. This report specifically reviews the evidence on the potential mechanisms by which smoking causes diseases and considers whether a mechanism is likely to be operative in the production of human disease by tobacco smoke. This evidence is relevant to understanding how smoking causes disease, to identifying those who may be particularly susceptible, and to assessing the potential risks of tobacco products.
Preventing Tobacco Use Among Youth and Young Adults
Author:
Publisher:
ISBN:
Category : Nicotine addiction
Languages : en
Pages : 22
Book Description
This booklet for schools, medical personnel, and parents contains highlights from the 2012 Surgeon General's report on tobacco use among youth and teens (ages 12 through 17) and young adults (ages 18 through 25). The report details the causes and the consequences of tobacco use among youth and young adults by focusing on the social, environmental, advertising, and marketing influences that encourage youth and young adults to initiate and sustain tobacco use. This is the first time tobacco data on young adults as a discrete population have been explored in detail. The report also highlights successful strategies to prevent young people from using tobacco.
Publisher:
ISBN:
Category : Nicotine addiction
Languages : en
Pages : 22
Book Description
This booklet for schools, medical personnel, and parents contains highlights from the 2012 Surgeon General's report on tobacco use among youth and teens (ages 12 through 17) and young adults (ages 18 through 25). The report details the causes and the consequences of tobacco use among youth and young adults by focusing on the social, environmental, advertising, and marketing influences that encourage youth and young adults to initiate and sustain tobacco use. This is the first time tobacco data on young adults as a discrete population have been explored in detail. The report also highlights successful strategies to prevent young people from using tobacco.
Reducing Tobacco-Related Cancer Incidence and Mortality
Author: Institute of Medicine
Publisher: National Academies Press
ISBN: 0309264014
Category : Medical
Languages : en
Pages : 131
Book Description
Tobacco use is the leading cause of preventable death in United States, causing more than 440,000 deaths annually and resulting in $193 billion in health-related economic losses each year-$96 billion in direct medical costs and $97 billion in lost productivity. Since the first U.S. Surgeon General's report on smoking in 1964, more than 29 Surgeon General's reports, drawing on data from thousands of studies, have documented the overwhelming and conclusive biologic, epidemiologic, behavioral, and pharmacologic evidence that tobacco use is deadly. This evidence base links tobacco use to the development of multiple types of cancer and other life-threatening conditions, including cardiovascular and respiratory diseases. Smoking accounts for at least 30 percent of all cancer deaths, and 80 percent of lung cancer deaths. Despite the widespread agreement on the dangers of tobacco use and considerable success in reducing tobacco use prevalence from over 40 percent at the time of the 1964 Surgeon General's report to less than 20 percent today, recent progress in reducing tobacco use has slowed. An estimated 18.9 percent of U.S. adults smoke cigarettes, nearly one in four high school seniors smoke, and 13 percent of high school males use smokeless tobacco products. In recognition that progress in combating cancer will not be fully achieved without addressing the tobacco problem, the National Cancer Policy Forum of the Institute of Medicine (IOM) convened a public workshop, Reducing Tobacco-Related Cancer Incidence and Mortality, June 11-12, 2012 in Washington, DC. In opening remarks to the workshop participants, planning committee chair Roy Herbst, professor of medicine and of pharmacology and chief of medical oncology at Yale Cancer Center and Smilow Cancer Hospital, described the goals of the workshop, which were to examine the current obstacles to tobacco control and to discuss potential policy, outreach, and treatment strategies that could overcome these obstacles and reduce tobacco-related cancer incidence and mortality. Experts explored a number of topics, including: the changing demographics of tobacco users and the changing patterns of tobacco product use; the influence of tobacco use on cancer incidence and cancer treatment outcomes; tobacco dependence and cessation programs; federal and state level laws and regulations to curtail tobacco use; tobacco control education, messaging, and advocacy; financial and legal challenges to tobacco control efforts; and research and infrastructure needs to support tobacco control strategies, reduce tobacco related cancer incidence, and improve cancer patient outcomes. Reducing Tobacco-Related Cancer Incidence and Mortality summarizes the workshop.
Publisher: National Academies Press
ISBN: 0309264014
Category : Medical
Languages : en
Pages : 131
Book Description
Tobacco use is the leading cause of preventable death in United States, causing more than 440,000 deaths annually and resulting in $193 billion in health-related economic losses each year-$96 billion in direct medical costs and $97 billion in lost productivity. Since the first U.S. Surgeon General's report on smoking in 1964, more than 29 Surgeon General's reports, drawing on data from thousands of studies, have documented the overwhelming and conclusive biologic, epidemiologic, behavioral, and pharmacologic evidence that tobacco use is deadly. This evidence base links tobacco use to the development of multiple types of cancer and other life-threatening conditions, including cardiovascular and respiratory diseases. Smoking accounts for at least 30 percent of all cancer deaths, and 80 percent of lung cancer deaths. Despite the widespread agreement on the dangers of tobacco use and considerable success in reducing tobacco use prevalence from over 40 percent at the time of the 1964 Surgeon General's report to less than 20 percent today, recent progress in reducing tobacco use has slowed. An estimated 18.9 percent of U.S. adults smoke cigarettes, nearly one in four high school seniors smoke, and 13 percent of high school males use smokeless tobacco products. In recognition that progress in combating cancer will not be fully achieved without addressing the tobacco problem, the National Cancer Policy Forum of the Institute of Medicine (IOM) convened a public workshop, Reducing Tobacco-Related Cancer Incidence and Mortality, June 11-12, 2012 in Washington, DC. In opening remarks to the workshop participants, planning committee chair Roy Herbst, professor of medicine and of pharmacology and chief of medical oncology at Yale Cancer Center and Smilow Cancer Hospital, described the goals of the workshop, which were to examine the current obstacles to tobacco control and to discuss potential policy, outreach, and treatment strategies that could overcome these obstacles and reduce tobacco-related cancer incidence and mortality. Experts explored a number of topics, including: the changing demographics of tobacco users and the changing patterns of tobacco product use; the influence of tobacco use on cancer incidence and cancer treatment outcomes; tobacco dependence and cessation programs; federal and state level laws and regulations to curtail tobacco use; tobacco control education, messaging, and advocacy; financial and legal challenges to tobacco control efforts; and research and infrastructure needs to support tobacco control strategies, reduce tobacco related cancer incidence, and improve cancer patient outcomes. Reducing Tobacco-Related Cancer Incidence and Mortality summarizes the workshop.